Tissue-Targeted Enzyme for Localized Tryptophan Catabolism to Direct Subcutaneous and Oral Mucosal Inflammatory Responses

用于局部色氨酸分解代谢的组织靶向酶以指导皮下和口腔粘膜炎症反应

基本信息

批准号：
9752509
负责人：
Benjamin George Keselowsky
金额：
$ 46.42万
依托单位：
UNIVERSITY OF FLORIDA
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-08-01 至 2021-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9752509
关键词：
Affinity Apoptosis Area Autoimmunity Avidity Binding Bone Resorption Carbohydrates Catabolism Cell physiology Cellular Metabolic Process Chimera organism Chimeric Proteins Chronic Consumption Data Dioxygenases Disease Environment Enzymes Essential Amino Acids Extracellular Matrix Family Galectin 3 Goals Homeostasis Immune Immune system Immunosuppressive Agents Immunotherapy In Vitro Individual Inflammation Inflammatory Inflammatory Response Investigation Kynurenine Lectin Leukocytes Lipopolysaccharides Luciferases Maintenance Mediating Metabolic Modeling Oral Oral mucous membrane structure Osteoclasts Pathway interactions Peptides Periodontal Diseases Pregnancy Process Production Regulatory T-Lymphocyte Surface T cell anergy T cell response T-Lymphocyte Technology Time Tissues Tooth Loss Treatment Efficacy Tryptophan Tryptophan Metabolism Pathway cancer therapy carbohydrate binding protein design effector T cell efficacy testing in vivo indoleamine innovation lactosamine member novel strategies overexpression programs response self assembly soft tissue subcutaneous transplant model

项目摘要

Project Summary/Abstract There is a considerable need for targeted technologies that direct the immune system for the controlled suppression of localized inflammation. Programming immune cell metabolism is a new and active area of investigation with numerous diverse immunotherapy applications. We are developing an innovative new approach of locally administering a tissue-targeted chimeric enzyme which catabolize the essential amino acid, tryptophan, and produces kynurenines, together inducing a powerful immunosuppressive metabolic programming. The chosen tissue targeting domain confers prolonged tissue retention, and the enzymatic activity can block local inflammation for an extended time. We are applying this technology for the amelioration of periodontal disease, in which localized non-resolving chronic inflammation is associated with a shift away from a submucosal environment rich in tolerance toward one of inflammation consisting of Th1 and Th17 T cells at the expense of regulatory T cells.

项目摘要/摘要有很大的需求将针对免疫系统的目标技术用于受控抑制局部炎症。编程免疫细胞代谢是一种新的和活跃的调查领域，具有多种免疫疗法的应用。我们是开发一种创新的新方法，用于局部管理针对组织的嵌合分解必需氨基酸，色氨酸并产生kynurenine的酶，共同诱导强大的免疫抑制代谢程序。选择的组织靶向域赋予长时间的组织保留率，酶活性可以阻止局部炎症长时间。我们正在应用这项技术来改善牙周疾病，其中局部非分辨慢性炎症与从宽松的环境中转向耐受性的粘膜环境，转向炎症之一以调节性T细胞为代价的Th1和Th17 T细胞。